@sailnyssa yes according to the MAGIC control data. We also need to remember that most of the pediatric patients treated with Ryoncil were those with the highest grades (C, D and C/D) who have the highest mortality rates.
I would go one step further @Zenox and say that the patients we treated had failed to respond to other treatments such as steroids etc
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-411
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |